To successfully commercialize a generic version of EXPAREL, The WhiteOak Group and Qilu Pharmaceutical would have to effectively litigate and overcome Pacira’s patents, manufacture these specific ...

SciSparc said its subsidiary, NeuroThera Labs, will purchase the treasury of patents, trademarks, and intellectual property rights from tech firm Xylo Technologies. The assets in the purchase are ...

SciSparc (SPRC)announced the signing of a binding term sheet to acquire a treasury of patents, trademarks and intellectual property rights for ...

Every November, we gather around tables filled with the fruits of hard work and gratitude. In innovation, that same kind of ...

According to a May 2025 market research report by MarkNtel Advisors, the global GERD device market was valued at ...

Kilpatrick’s Jennifer Andrews and Matt Crookston recently presented on the topic of “The Changing Framework of Intellectual Property Rights ...

U.S. patent litigation, driven by pro-patent policies, advanced AI tools, and increased litigation funding, all boosting enforcement and enforcement success.

No one can legitimately create a monopoly on ideas. The problems of freedom are solved with more freedom and worsened with ...

You know the feeling. You finally validate an idea, build a prototype, and start talking to customers. Then a friend sends ...

In this article, Ben Lincoln covers how Tulip Innovation’s patent action against Sunwoda Group illustrate the growing role of ...

The “Litigation Transparency Act of 2025,” which would curb the use of third-party litigation funding in U.S. lawsuits, ...